Page 3 - Disease Research Program News Today

Compared to urban dwellers, racially/ethnically diverse older adults face up to an 80 percent greater risk of cognitive impairment in older age, and 2.5 times p

Compared to urban dwellers, racially/ethnically diverse older adults face up to an 80 percent greater risk of cognitive impairment in older age, and 2.5 times p

UC Davis Chancellor condemns faculty member’s social media posts UC Davis Chancellor Gary May released a statement on Oct. 19 condemning a faculty member’s posts on the social media platform X, calling the posts “revolting in every way.” In one post, the faculty member — whose name and position were not mentioned — threatened “Zionist

Roughly one in eight peri- and postmenopausal women say they use cannabis for medical reasons, according to a new study presented at the 2023 annual meeting of The Menopause Society.

With $3.7 million in funding, the UC Davis Comprehensive Cancer Center is set to launch the Tobacco Cessation Policy Research Center    By KAYA

UC Davis Comprehensive Cancer Center has launched the state’s first-ever Tobacco Cessation Policy Research Center.

People who use both cannabis and tobacco have significantly higher rates of depression and anxiety than those who use either substance alone or not at all, according to a new study by UC San Francisco researchers.

People who use both tobacco and cannabis are more likely to report anxiety and depression than those who used tobacco only or those used neither substance, according to a new study published this week in the open-access journal PLOS ONE by Nhung Nguyen of the University of California, San Francisco, USA, and colleagues.

Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, today published a new study explaining how

Researchers at City of Hope today published a new study explaining how they took a protein once thought to be too challenging for targeted therapy, proliferating cell nuclear antigen (PCNA), and developed a targeted chemotherapy that appears to annihilate all solid tumors in preclinical research. As the scientists continue to investigate the foundational mechanisms that make this cancer-stopping pill work in animal models, they note that there is an ongoing Phase 1 clinical trial testing the Cit...